Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine. [PDF]
Mol Ther Methods Clin Dev, 2022 Engeland CE.
europepmc +1 more source
Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic. [PDF]
Vaccines (Basel), 2023 Yang Y +14 more
europepmc +1 more source
A FIELD TRIAL OF FURTHER ATTENUATED LIVE MEASLES VIRUS VACCINES IN JAPAN, 1968
, 1969 Akira Shishido
openalex +2 more sources
Chorioallantoic Membrane Measles: Development and Clinical Evaluation of a New Further Attenuated Measles Vaccine [PDF]
, 1974 Costantino P. Cerini +4 more
openalex +1 more source
Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia. [PDF]
Pan Afr Med J, 2021 Desta T +5 more
europepmc +1 more source
How a generally well-accepted measles vaccine mandate may lead to inequities and decreased vaccine uptake: a preregistered survey study in Germany. [PDF]
BMC Public Health, 2022 Neufeind J +4 more
europepmc +1 more source
The Effect of a Second Dose of Measles Vaccine at 18 Months of Age on Nonaccidental Deaths and Hospital Admissions in Guinea-Bissau: Interim Analysis of a Randomized Controlled Trial. [PDF]
Clin Infect Dis, 2022 Berendsen MLT +7 more
europepmc +1 more source
The role of secondary vaccine failures in measles outbreaks. [PDF]
, 1989 Richard Mathias +3 more
openalex +1 more source